Clinical Trial Update: Clinical Trial of Ventiflow LP Supporting High-risk Percutaneous Coronary Intervention(PCI) [NA]

View source ↗

Summary

Clinical trial update for Ventiflow LP showing a NOT_YET_RECRUITING status for a high-risk PCI study sponsored by Suzhou Hearthill Medical Technology Co., LTD. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Heart Failure

Drugs mentioned

• Ventiflow LP

Snippet

Sponsor: Suzhou Hearthill Medical Technology Co.,LTD | Conditions: Coronary Artery Disease, Heart Failure | NA | Status: NOT_YET_RECRUITING